0
The State Policy Context of Implementation Issues for Evidence-Based Practices in Mental Health
Kimberley R. Isett, Ph.D., M.P.A.; M. Audrey Burnam, Ph.D.; Brenda Coleman-Beattie, M.A.; Pamela S. Hyde, J.D.; Joseph P. Morrissey, Ph.D.; Jennifer Magnabosco, Ph.D.; Charles A. Rapp, Ph.D.; Vijay Ganju, Ph.D.; Howard H. Goldman, M.D., Ph.D.
Long-Term Employment Trajectories Among Participants With Severe Mental Illness in Supported Employment
Deborah Becker, M.Ed.; Rob Whitley, Ph.D.; Edward L. Bailey, M.S.; Robert E. Drake, M.D., Ph.D.
Predictors of Mental Health Service Utilization by People Using Resources for Homeless People in Canada
Jean-Pierre Bonin, Ph.D.; Louise Fournier, Ph.D.; Régis Blais, Ph.D.
Treatment for Co-occurring Mental and Substance Use Disorders in Five State Medicaid Programs
Robin E. Clark, Ph.D.; Mihail Samnaliev, Ph.D.; Mark P. McGovern, Ph.D.
Co-occurring Psychiatric and Substance Use Disorders: A Multistate Feasibility Study of the Quadrant Model
Mark P. McGovern, Ph.D.; Robin E. Clark, Ph.D.; Mihail Samnaliev, Ph.D.
A Peer-Support, Group Intervention to Reduce Substance Use and Criminality Among Persons With Severe Mental Illness
Michael Rowe, Ph.D.; Chyrell Bellamy, Ph.D., M.S.W.; Madelon Baranoski, Ph.D.; Melissa Wieland, Ph.D., M.P.H.; Maria J. O'Connell, Ph.D.; Patricia Benedict, B.A.; Larry Davidson, Ph.D.; Josephine Buchanan, B.A.; Dave Sells, Ph.D.
Use of Mental Health Care Services by Canadians With Co-occurring Substance Dependence and Mental Disorders
Karen A. Urbanoski, M.Sc.; Brian R. Rush, Ph.D.; T. Cameron Wild, Ph.D.; Diego G. Bassani, Ph.D.; Saulo Castel, M.D., Ph.D.
Health-Related Quality of Life Among First-Degree Relatives of Patients With Obsessive-Compulsive Disorder in Italy
Umberto Albert, M.D., Ph.D.; Virginio Salvi, M.D.; Paola Saracco, Psy.D.; Filippo Bogetto, M.D.; Giuseppe Maina, M.D.
Treatment Seeking by Individuals With Obsessive-Compulsive Disorder From the British Psychiatric Morbidity Survey of 2000
Albina R. Torres, M.D., Ph.D.; Martin J. Prince, M.D., M.R.C.Psych.; Paul E. Bebbington, Ph.D., F.R.C.Psych.; Dinesh K. Bhugra, Ph.D., F.R.C.Psych.; Traolach S. Brugha, M.D., F.R.C.Psych.; Michael Farrell, M.R.C.P., M.R.C.Psych.; Rachel Jenkins, M.D., F.R.C.Psych.; Glyn Lewis, Ph.D., F.R.C.Psych.; Howard Meltzer, Ph.D.; Nicola Singleton, B.Sc., M.Sc.
Adding or Switching Antipsychotic Medications in Treatment-Refractory Schizophrenia
Julie Kreyenbuhl, Pharm.D., Ph.D.; Steven C. Marcus, Ph.D.; Joyce C. West, Ph.D., M.P.P.; Joshua Wilk, Ph.D.; Mark Olfson, M.D., M.P.H.
Antipsychotic Polypharmacy Trends Among Medi-Cal Beneficiaries With Schizophrenia in San Diego County, 1999–2004
Todd P. Gilmer, Ph.D.; Christian R. Dolder, Pharm.D.; David P. Folsom, M.D., M.P.H.; William Mastin, Pharm.D.; Dilip V. Jeste, M.D.